From Small Data to Big Decisions: How Clinical Pharmacology Shapes Rare Disease Development

Yan Xu, Alissa Verone‐Boyle, Natalie Schmitz, Hamim Zahir, Brian A. Willis

Open source

DOI
10.1002/jcph.70250
Published
2026-07-31
Container
The Journal of Clinical Pharmacology
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/jcph.70250,
  title = {From Small Data to Big Decisions: How Clinical Pharmacology Shapes Rare Disease Development},
  author = {Yan Xu and Alissa Verone‐Boyle and Natalie Schmitz and Hamim Zahir and Brian A. Willis},
  year = {2026},
  journal = {The Journal of Clinical Pharmacology},
  doi = {10.1002/jcph.70250},
  url = {https://doi.org/10.1002/jcph.70250}
}

RIS

TY  - JOUR
TI  - From Small Data to Big Decisions: How Clinical Pharmacology Shapes Rare Disease Development
AU  - Yan Xu
AU  - Alissa Verone‐Boyle
AU  - Natalie Schmitz
AU  - Hamim Zahir
AU  - Brian A. Willis
PY  - 2026
JO  - The Journal of Clinical Pharmacology
DO  - 10.1002/jcph.70250
UR  - https://doi.org/10.1002/jcph.70250
ER  - 

APA

Xu, Y., Verone‐Boyle, A., Schmitz, N., Zahir, H., & Willis, B. A. (2026). From Small Data to Big Decisions: How Clinical Pharmacology Shapes Rare Disease Development. The Journal of Clinical Pharmacology. https://doi.org/10.1002/jcph.70250

Source records